Exelixis
EXEL
#1590
Rank
HK$107.96 B
Marketcap
HK$429.54
Share price
2.89%
Change (1 day)
24.14%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company